Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 107256
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107256
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107256
Figure 2 Pair-wise comparisons among groups with differing fibrosis status (total n = 420, no fibrosis group n = 27, liver fibrosis group n = 121, and cirrhosis group n = 272).
A: Alanine aminotransferase; B: Aspartate aminotransferase; C: Alkaline phosphatase; D: Aspartate aminotran sferase/alanine aminotransferase ratio. The Wilcoxon rank-sum test was used for intergroup comparisons of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and aspartate aminotransferase/alanine aminotransferase ratio. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; S/L: Aspartate aminotransferase/alanine aminotransferase ratio. aP < 0.05, bP < 0.001.
- Citation: Luo Y, Li R, Kang J, Zhao BN, Lan LJ, Gao FJ, Ren XX, Zhu YF, Liu DF. Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis. World J Diabetes 2025; 16(7): 107256
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/107256.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.107256